Literature DB >> 16170160

Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study.

Daniel C Bowers1, D Elizabeth McNeil, Yan Liu, Yutaka Yasui, Marilyn Stovall, James G Gurney, Melissa M Hudson, Sarah S Donaldson, Roger J Packer, Pauline A Mitby, Catherine E Kasper, Leslie L Robison, Kevin C Oeffinger.   

Abstract

PURPOSE: The objectives of this report are to examine the incidence of and risk factors for stroke among childhood Hodgkin's disease (HD) survivors. PATIENTS AND METHODS: The Childhood Cancer Survivor Study is a multi-institutional cohort study of more than 5-year cancer survivors diagnosed between 1970 and 1986 and a sibling comparison group. Incidence rates of stroke among HD survivors (n = 1,926) and siblings (n = 3,846) were calculated and compared. Cox proportional hazards models were used to estimate the hazard ratios, reported as relative risks (RR), of developing stroke between HD survivors and siblings.
RESULTS: Nine siblings reported a stroke, for an incidence of 8.00 per 100,000 person-years (95% CI, 3.85 to 14.43 per 100,000 person-years). Twenty-four HD survivors reported a stroke. The incidence of late-occurring stroke among HD survivors was 83.6 per 100,000 person-years (95% CI, 54.5 to 121.7 per 100,000 person-years). The RR of stroke among HD survivors was 4.32 (95% CI, 2.01 to 9.29; P = .0002). All 24 survivors received mantle radiation exposure (median dose, 40 Gy). The incidence of late-occurring stroke among HD survivors treated with mantle radiation was 109.8 per 100,000 person-years (95% CI, 70.8 to 161.1 per 100,000 person-years). The RR of late-occurring stroke among HD survivors treated with mantle radiation was 5.62 (95% CI, 2.59 to 12.25; P < .0001).
CONCLUSION: Survivors of childhood HD are at increased risk of stroke. Mantle radiation exposure is strongly associated with subsequent stroke. Potential mechanisms may include carotid artery disease or cardiac valvular disease.

Entities:  

Mesh:

Year:  2005        PMID: 16170160     DOI: 10.1200/JCO.2005.15.107

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   50.717


  67 in total

Review 1.  Late effects of therapy for Hodgkin's lymphoma.

Authors:  Michael Jacob Adams; Louis S Constine; Steven E Lipshultz
Journal:  Curr Hematol Malig Rep       Date:  2007-07       Impact factor: 3.952

2.  Building a bridge of continued care for cancer survivors.

Authors: 
Journal:  J Oncol Pract       Date:  2006-03       Impact factor: 3.840

3.  Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group.

Authors:  Suzanne L Wolden; Lu Chen; Kara M Kelly; Philip Herzog; Gerald S Gilchrist; John Thomson; Richard Sposto; Marshall E Kadin; Raymond J Hutchinson; James Nachman
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

4.  Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.

Authors:  Sharon M Castellino; Ann M Geiger; Ann C Mertens; Wendy M Leisenring; Janet A Tooze; Pam Goodman; Marilyn Stovall; Leslie L Robison; Melissa M Hudson
Journal:  Blood       Date:  2010-10-29       Impact factor: 22.113

5.  Health knowledge about symptoms of heart attack and stroke in adult survivors of childhood acute lymphoblastic leukemia.

Authors:  James G Gurney; Janet E Donohue; Kirsten K Ness; Maura O'Leary; Stephen P Glasser; K Scott Baker
Journal:  Ann Epidemiol       Date:  2007-07-27       Impact factor: 3.797

6.  Stroke due to doxorubicin-induced cardiac toxicity.

Authors:  Gamze Kara; Ozlem Taşoğlu; Omer Dizdar; Kadri Altundağ; Levent Ozçakar
Journal:  Med Oncol       Date:  2008-11-22       Impact factor: 3.064

Review 7.  Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings.

Authors:  Lisa Diller; Eric J Chow; James G Gurney; Melissa M Hudson; Nina S Kadin-Lottick; Toana I Kawashima; Wendy M Leisenring; Lillian R Meacham; Ann C Mertens; Daniel A Mulrooney; Kevin C Oeffinger; Roger J Packer; Leslie L Robison; Charles A Sklar
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

Review 8.  Physical performance limitations in the Childhood Cancer Survivor Study cohort.

Authors:  Kirsten K Ness; Melissa M Hudson; Jill P Ginsberg; Rajaram Nagarajan; Sue C Kaste; Neyssa Marina; John Whitton; Leslie L Robison; James G Gurney
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

9.  Radiation-induced cardiovascular disease.

Authors:  Negareh Mousavi; Anju Nohria
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

10.  Direct Observation of Early-Stage High-Dose Radiotherapy-Induced Vascular Injury via Basement Membrane-Targeting Nanoparticles.

Authors:  Kin Man Au; Sayed Nabeel Hyder; Kyle Wagner; Caihong Shi; Young Seok Kim; Joseph M Caster; Xi Tian; Yuanzeng Min; Andrew Z Wang
Journal:  Small       Date:  2015-11-18       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.